Chen Y, Xiang X, Wang Z, Miao C, Xu Z
Pediatr Investig. 2023; 7(3):191-198.
PMID: 37736368
PMC: 10509407.
DOI: 10.1002/ped4.12395.
Chun J, Yoon Y, Choe Y, Kang L, Paik S, Park C
Ann Dermatol. 2017; 29(4):422-426.
PMID: 28761289
PMC: 5500706.
DOI: 10.5021/ad.2017.29.4.422.
Roh N, Han S, Youn H, Kim Y, Lee Y, Choe Y
Ann Dermatol. 2016; 27(6):738-43.
PMID: 26719644
PMC: 4695427.
DOI: 10.5021/ad.2015.27.6.738.
Vakirlis E, Kastanis A, Ioannides D
Ther Clin Risk Manag. 2008; 4(1):141-8.
PMID: 18728704
PMC: 2503650.
DOI: 10.2147/tcrm.s1478.
Breathnach S
Clin Exp Immunol. 1993; 91(3):343-5.
PMID: 8443957
PMC: 1554704.
DOI: 10.1111/j.1365-2249.1993.tb05906.x.
Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice.
Boehncke W, Sterry W, Hainzl A, Scheffold W, Kaufmann R
Arch Dermatol Res. 1994; 286(6):325-30.
PMID: 7979548
DOI: 10.1007/BF00402223.
Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo.
Boehncke W, Konig K, Kaufmann R, Scheffold W, Prummer O, Sterry W
Arch Dermatol Res. 1994; 286(6):300-3.
PMID: 7979545
DOI: 10.1007/BF00402219.
Excessive costimulation of CD3-dependent lymphocyte response by extracellular matrix proteins in severe widespread psoriasis.
Glinski W, Gorski A, Majewski S
Arch Dermatol Res. 1995; 287(2):176-9.
PMID: 7763090
DOI: 10.1007/BF01262328.
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Faulds D, Goa K, Benfield P
Drugs. 1993; 45(6):953-1040.
PMID: 7691501
DOI: 10.2165/00003495-199345060-00007.
Confirmation of genetic heterogeneity in familial psoriasis.
Matthews D, Fry L, Powles A, Weissenbach J, Williamson R
J Med Genet. 1995; 32(7):546-8.
PMID: 7562968
PMC: 1050548.
DOI: 10.1136/jmg.32.7.546.
Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin.
de Boer O, Wakelkamp I, Pals S, Claessen N, Bos J, Das P
Arch Dermatol Res. 1994; 286(6):304-11.
PMID: 7526804
DOI: 10.1007/BF00402220.
Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432.
Aiba S, Tagami H
Arch Dermatol Res. 1989; 281(5):310-5.
PMID: 2679407
DOI: 10.1007/BF00412973.
Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris.
Vonderheid E, Bigler R, Rogers T, Kadin M, Griffin T
Yale J Biol Med. 1989; 62(6):653-64.
PMID: 2636805
PMC: 2589147.
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin.
Bos J, Hagenaars C, Das P, Krieg S, Voorn W, Kapsenberg M
Arch Dermatol Res. 1989; 281(1):24-30.
PMID: 2525009
DOI: 10.1007/BF00424268.
The psoriatic epidermal lesion and anagen hair growth may share the same "switch-on" mechanism.
Paus R, Link R
Yale J Biol Med. 1988; 61(5):467-76.
PMID: 2462312
PMC: 2590431.
Keratinocyte growth regulation by the products of immune cells.
Hancock G, Kaplan G, COHN Z
J Exp Med. 1988; 168(4):1395-402.
PMID: 2459297
PMC: 2189076.
DOI: 10.1084/jem.168.4.1395.
The practical use of methotrexate in psoriasis.
Tung J, Maibach H
Drugs. 1990; 40(5):697-712.
PMID: 2292232
DOI: 10.2165/00003495-199040050-00005.
Dermatology.
Rustin M
Postgrad Med J. 1990; 66(781):894-905.
PMID: 2148371
PMC: 2429766.
DOI: 10.1136/pgmj.66.781.894.
Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.
Glinski W, Jablonska S
Arch Dermatol Res. 1991; 283(4):224-9.
PMID: 1929539
DOI: 10.1007/BF01106106.
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff B, Karabin G, Barker J, Griffiths C, Sarma V, Mitra R
Am J Pathol. 1991; 138(1):129-40.
PMID: 1702929
PMC: 1886036.
